Carry Life@ UF System Clinical Study

NAEnrolling by invitationINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 19, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

November 30, 2025

Conditions
End Stage Renal Disease
Interventions
DEVICE

Carry Life UF

A 5-hour treatment with the Carry Life UF used with a 1.36% glucose PD fill.

DRUG

2.27% glucose peritoneal dialysis dwell

A 5-hour CAPD dwell with a 2.27% glucose PD fluid.

Trial Locations (12)

Unknown

ASST-Cremona, Cremona

Polyclinic Milan, Milan

P.O. San Giovanni Bosco, Torino

Sahlgrenska Universitetssjukhuset, Gothenburg

Skånes University Hospital, Lund

Karolinska Universitetssjukhuset, Njurmedicin Rosenlund, Stockholm

Heartlands Hospital, Birmingham

Queen Elisabeth's Hospital, Birmingham

King's College Hospital, London

London Royal Hospital, Barth Health NHS Trust, London

Royal Free London NHS Foundation Trust, London

Nottingham University Hospitals NHS Trust, Nottingham

All Listed Sponsors
collaborator

Iqvia Pty Ltd

INDUSTRY

lead

Triomed AB

INDUSTRY